JPS5271467A - Production of pyrazolone derivatives and use of the same as pharmaceutical agent - Google Patents
Production of pyrazolone derivatives and use of the same as pharmaceutical agentInfo
- Publication number
- JPS5271467A JPS5271467A JP51144842A JP14484276A JPS5271467A JP S5271467 A JPS5271467 A JP S5271467A JP 51144842 A JP51144842 A JP 51144842A JP 14484276 A JP14484276 A JP 14484276A JP S5271467 A JPS5271467 A JP S5271467A
- Authority
- JP
- Japan
- Prior art keywords
- production
- same
- pharmaceutical agent
- pyrazolone derivatives
- pyrazolone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/28—Two oxygen or sulfur atoms
- C07D231/30—Two oxygen or sulfur atoms attached in positions 3 and 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/28—Two oxygen or sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19752554701 DE2554701A1 (en) | 1975-12-05 | 1975-12-05 | 3,4-DISUBSTITUTED 2- (BETA-NAPHTHYLOXY) -AETHYLPYRAZOLONE |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS5271467A true JPS5271467A (en) | 1977-06-14 |
Family
ID=5963526
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51144842A Pending JPS5271467A (en) | 1975-12-05 | 1976-12-03 | Production of pyrazolone derivatives and use of the same as pharmaceutical agent |
Country Status (9)
Country | Link |
---|---|
JP (1) | JPS5271467A (en) |
BE (1) | BE849047A (en) |
DE (1) | DE2554701A1 (en) |
DK (1) | DK545676A (en) |
ES (1) | ES453908A1 (en) |
FR (1) | FR2333505A1 (en) |
LU (1) | LU76328A1 (en) |
NL (1) | NL7613451A (en) |
SE (1) | SE7613536L (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3432062A1 (en) * | 1984-08-31 | 1986-03-06 | Bayer Ag, 5090 Leverkusen | PYRAZOLDION DERIVATIVES AND THEIR APPLICATION IN THE FIGHT AGAINST DISEASES |
JP3994453B2 (en) * | 1995-10-13 | 2007-10-17 | 日産化学工業株式会社 | Pyrazolones |
CN104945294B (en) * | 2014-03-31 | 2016-09-07 | 中国科学院上海有机化学研究所 | Compound containing trifluoromethylthio and preparation method thereof |
CN104974065A (en) * | 2015-06-15 | 2015-10-14 | 华东理工大学 | Method for preparing alpha-trifluoromethylthio-one |
-
1975
- 1975-12-05 DE DE19752554701 patent/DE2554701A1/en not_active Withdrawn
-
1976
- 1976-12-02 NL NL7613451A patent/NL7613451A/en not_active Application Discontinuation
- 1976-12-02 SE SE7613536A patent/SE7613536L/en unknown
- 1976-12-03 JP JP51144842A patent/JPS5271467A/en active Pending
- 1976-12-03 FR FR7636543A patent/FR2333505A1/en not_active Withdrawn
- 1976-12-03 ES ES453908A patent/ES453908A1/en not_active Expired
- 1976-12-03 DK DK545676A patent/DK545676A/en unknown
- 1976-12-03 LU LU76328A patent/LU76328A1/xx unknown
- 1976-12-03 BE BE172954A patent/BE849047A/en unknown
Also Published As
Publication number | Publication date |
---|---|
BE849047A (en) | 1977-06-03 |
NL7613451A (en) | 1977-06-07 |
DK545676A (en) | 1977-06-06 |
ES453908A1 (en) | 1977-11-16 |
LU76328A1 (en) | 1977-11-21 |
SE7613536L (en) | 1977-06-06 |
DE2554701A1 (en) | 1977-06-08 |
FR2333505A1 (en) | 1977-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ180529A (en) | Erythromyc-9-yl-amine derivatives and pharmaceutical compositions | |
GB1520447A (en) | Benzisoquinoline derivatives and pharmaceutical uses thereof | |
JPS52131564A (en) | Production of naphthaline derivatives and use thereof | |
JPS5251367A (en) | Production of novel substituted 44aminopyrazole and pharmaceutical agent containing the same | |
PH16022A (en) | Acylamino derivatives and pharmaceutical compositions thereof | |
JPS5253863A (en) | Production of thiazole derivatives and pharmaceutical composition containing the same with tranquilizing action | |
JPS52105168A (en) | Production of 1*22 benzisothiazolinee33ones and use of same as pharmaceutical agent | |
JPS5268177A (en) | Production of indazole derivatives and pharmaceutical composition containing the same | |
IL51017A0 (en) | The preparation of certain penicillin derivatives | |
JPS527999A (en) | Production of evrnamenine derivatives and pharmaceutical composition | |
JPS52268A (en) | Production of pyrazole * pharmaceutical agent and composition | |
JPS5236666A (en) | Production novel pyrazole derivatives and antii inflammatory agent containing the same | |
NZ182161A (en) | Alkoxy-pyridine-carobxamide derivatives and pharmaceutical compositions | |
NZ184102A (en) | Derivatives of benzenesulphonylurea,and pharmaceutical compositions | |
JPS51141862A (en) | Production of cardenolide derivatives and pharmaceutical composition containing the same | |
JPS5271467A (en) | Production of pyrazolone derivatives and use of the same as pharmaceutical agent | |
JPS52267A (en) | Production of pyrazole * pharmaceutical agent and composition | |
JPS5363348A (en) | Derivative of substituted oophenylenediamine * method of its production and its use as drug | |
JPS51125383A (en) | Production of thiazolinone and pharmaceutical composition containing the same | |
NZ181727A (en) | Pyrroline-2-one derivatives and pharmaceutical compositions | |
JPS5262278A (en) | Production of novel imidazole compound and pharmaceutical agent | |
JPS51133264A (en) | Novel 111oxaaprostaglandine homologue * derivatives and production of the same | |
JPS523051A (en) | Production of fusidic acid derivatives and pharmaceutical agent containing the same | |
NZ181401A (en) | 2-benzopyranone derivatives and pharmaceutical compositions | |
GB1533491A (en) | Cephalosporin derivatives and the preparation thereof |